DK0531845T3 - Farmaceutiske præparater med en speciel krystalmodifikation af 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarboxylsyre-isopropyl-(2-methoxyethyl)-ester - Google Patents
Farmaceutiske præparater med en speciel krystalmodifikation af 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarboxylsyre-isopropyl-(2-methoxyethyl)-esterInfo
- Publication number
- DK0531845T3 DK0531845T3 DK92114835.9T DK92114835T DK0531845T3 DK 0531845 T3 DK0531845 T3 DK 0531845T3 DK 92114835 T DK92114835 T DK 92114835T DK 0531845 T3 DK0531845 T3 DK 0531845T3
- Authority
- DK
- Denmark
- Prior art keywords
- methoxyethyl
- nitrophenyl
- dihydro
- dimethyl
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4130173A DE4130173A1 (de) | 1991-09-11 | 1991-09-11 | Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsaeure-isopropyl-(2-methoxyethyl)-esters |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0531845T3 true DK0531845T3 (da) | 1996-11-25 |
Family
ID=6440342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92114835.9T DK0531845T3 (da) | 1991-09-11 | 1992-08-31 | Farmaceutiske præparater med en speciel krystalmodifikation af 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarboxylsyre-isopropyl-(2-methoxyethyl)-ester |
Country Status (11)
Country | Link |
---|---|
US (1) | US5599824A (da) |
EP (1) | EP0531845B1 (da) |
JP (1) | JPH05229945A (da) |
AT (1) | ATE141052T1 (da) |
CA (1) | CA2077704C (da) |
DE (2) | DE4130173A1 (da) |
DK (1) | DK0531845T3 (da) |
ES (1) | ES2090432T3 (da) |
GR (1) | GR3020962T3 (da) |
HK (1) | HK41697A (da) |
MX (1) | MX9205077A (da) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6287693B1 (en) | 1998-02-25 | 2001-09-11 | John Claude Savoir | Stable shaped particles of crystalline organic compounds |
AU2004246870B2 (en) | 2003-06-13 | 2009-07-23 | Skendi Finance Ltd | Slow release estradiol-progesterone formulation for contraception and hormone replacement therapy |
CN1824647B (zh) * | 2005-02-22 | 2011-04-20 | 田边三菱制药株式会社 | (±)2-(二甲基氨基)-1-{[O-(m-甲氧基苯乙基)苯氧基]甲基}乙基氢琥珀酸酯盐酸盐的晶体 |
US9399019B2 (en) | 2012-05-09 | 2016-07-26 | Evonik Corporation | Polymorph compositions, methods of making, and uses thereof |
US20180098977A1 (en) * | 2016-08-23 | 2018-04-12 | Edge Therapeutics, Inc. | Scalable microparticulate formulations containing polymorphic nimodipine form 2 prepared by a solvent evaporation process |
WO2019018306A1 (en) * | 2017-07-17 | 2019-01-24 | Edge Therapeutics, Inc. | ADVANCED MICROPARTICULAR FORMULATIONS CONTAINING FORM 2 OF MICRONIZED POLYMORPHIC NIMODIPINE |
USD867911S1 (en) * | 2018-10-10 | 2019-11-26 | Adel J M S Alabdin | Combination gas leak sensor and communication device |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3932645A (en) * | 1971-04-10 | 1976-01-13 | Farbenfabriken Bayer Ag | Pharmaceutical compositions containing unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylic acid |
DE2815578C2 (de) * | 1978-04-11 | 1986-01-16 | Bayer Ag, 5090 Leverkusen | Neue pharmazeutische Verwendung von Nimodipin |
DE3033919A1 (de) * | 1980-09-09 | 1982-04-22 | Bayer Ag, 5090 Leverkusen | Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung |
DE3318649A1 (de) * | 1983-05-21 | 1984-11-22 | Bayer Ag, 5090 Leverkusen | Zweiphasenformulierung |
DE3424553A1 (de) * | 1984-07-04 | 1986-01-09 | Bayer Ag, 5090 Leverkusen | Feste arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung |
GB8729471D0 (en) * | 1987-12-17 | 1988-02-03 | Wyeth John & Brother Ltd | New crystal form |
-
1991
- 1991-09-11 DE DE4130173A patent/DE4130173A1/de not_active Withdrawn
-
1992
- 1992-08-31 ES ES92114835T patent/ES2090432T3/es not_active Expired - Lifetime
- 1992-08-31 AT AT92114835T patent/ATE141052T1/de active
- 1992-08-31 EP EP92114835A patent/EP0531845B1/de not_active Expired - Lifetime
- 1992-08-31 DE DE59206868T patent/DE59206868D1/de not_active Expired - Lifetime
- 1992-08-31 DK DK92114835.9T patent/DK0531845T3/da active
- 1992-09-04 MX MX9205077A patent/MX9205077A/es unknown
- 1992-09-08 CA CA002077704A patent/CA2077704C/en not_active Expired - Lifetime
- 1992-09-10 JP JP4266843A patent/JPH05229945A/ja active Pending
-
1995
- 1995-01-30 US US08/380,229 patent/US5599824A/en not_active Expired - Lifetime
-
1996
- 1996-09-05 GR GR960402317T patent/GR3020962T3/el unknown
-
1997
- 1997-04-03 HK HK41697A patent/HK41697A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE4130173A1 (de) | 1993-03-18 |
CA2077704A1 (en) | 1993-03-12 |
JPH05229945A (ja) | 1993-09-07 |
DE59206868D1 (de) | 1996-09-12 |
CA2077704C (en) | 2003-03-11 |
ES2090432T3 (es) | 1996-10-16 |
US5599824A (en) | 1997-02-04 |
EP0531845B1 (de) | 1996-08-07 |
HK41697A (en) | 1997-04-11 |
GR3020962T3 (en) | 1996-12-31 |
ATE141052T1 (de) | 1996-08-15 |
MX9205077A (es) | 1993-03-01 |
EP0531845A1 (de) | 1993-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA6344A1 (uk) | Спосіб одержання бензолсульфонатної солі 3-етіл-5метілового ефіру 2-(2-аміноетоксіметіл)-4-(2-хлорфеніл)-6-метіл-1,4-дігідропірідін-3,5-дікарбонової кислоти | |
DK63085D0 (da) | Asymmetriske diestere af 1,4-dihydro-2,6-dimethyl-pyridin-3,5-dicarboxylsyre | |
JPS55301A (en) | 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation | |
MX9205215A (es) | Procedimiento novedoso para la preparacion de 1,4-dihidropiridina 4-substituida | |
MX9708662A (es) | Un procedimiento para la preparacion de clorhidrato de lercanidipino. | |
AU557175B2 (en) | 2,6-dimethyl-4-(3-nitro phenyl)-1,4-dihydro pyridine-3,5- dicarboxylic acid esters | |
DK0531845T3 (da) | Farmaceutiske præparater med en speciel krystalmodifikation af 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarboxylsyre-isopropyl-(2-methoxyethyl)-ester | |
UA27719C2 (uk) | Ефіри 2,6-диметил-1,4-дигідропіридин-3-карбонової кислоти, що є блокаторами кальцієвих каналів, спосіб їх одержання та фармацевтична композиція | |
SE433211B (sv) | Analogiforfarande for framstellning av 1,4-dehydro-2,6-dimetyl-4-(3-nitrofenyl)-3,5-pyridindikarbonsyra-isopropyl-(2-propoxietyl)-ester | |
GR890100133A (el) | Μεθοδος παρασκευης παραγωγων 1,4 διυδροπυριδινης. | |
EP0207674A3 (en) | 1,4-dihydropyridine derivatives, their preparation and their pharmaceutical use | |
EP0445987A3 (en) | Novel process for producing 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate-3-methyl ester-5-beta-(n-benzyl-n-methylamino)ethyl ester | |
DK166386C (da) | Diastereoisomer a af 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-3-(1-benzylpyrrolidin-3-yl)ester-5-methylester, den hoejredrejende optiske isomer heraf, fremgangsmaader til fremstilling af forbindelserne og farmaceutiske praeparater indeholdende disse | |
PT84566B (pt) | Processo para a preparacao do novo composto com actividade optica (+)-1,4- -dihidro-2,6-dimetil-4-(3-nitrofenil)-piridina-3,5-dicarboxilato de 3-metil-5- -{3-(4,4-difenil-piperidil-1)-profilo} e de composicoes farmaceuticas que o contem | |
IL104357A0 (en) | Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester,its preparation and pharmaceutical compositions containing it | |
DK468385A (da) | Fremgangsmaade til fremstilling af den optiske d-isomer af diastereomeren aeaae af 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-3-(1-benzylpyrrolidin-3-yl)-ester-5-methylester | |
ATE126190T1 (de) | 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-5- | |
EP0167068A3 (en) | Isopropyl-2û2-(3-trifluoromethylphenoxy)ethyl¨ester of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine-3,5-dicarboxylic acid, process for its preparation, and its use as a medicine | |
RU1828464C (ru) | Способ получени диметилового эфира 1,4-дигидро-2,6-диметил-4-/2 @ -нитрофенил/-пиридин-3,5-дикарбоновой кислоты | |
LV5619A3 (lv) | Panemiens 2-(2-aminoetoksimetil)-4-(2-hlorfenil)-6-metil-1,4-dihidropiridina-3,5-dikarbonskabes 3-etil-5-metilestera benzolsulfoskabes sais iegusanai | |
YU188386A (en) | Process for obtaining asymmetric diesthers of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarboxylic acid | |
AU626404B2 (en) | A controlled release formulation of 4-(2,1,3-benzoxadizaol-4 -yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester | |
YU66687A (en) | Process for obtaining hydrochloride of 2(n-benzyl-n-m-ethylamino)-ethyl-methyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridin-dicarboxilate | |
IL81998A (en) | Optically active 3-methyl-5-(3-(4,4-diphenylpiperid-1-yl)-propyl)-(+)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine-3,5-dicarboxylate and its salts,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL106369A0 (en) | A specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester,its preparation and pharmaceutical compositions containing it |